Trillium Therapeutics Secures FDA Breakthrough Therapy Designation for TTI-622
**Trillium Therapeutics Receives FDA Breakthrough Therapy Designation for TTI-622 Development** Trillium Therapeutics Inc. announced the granting of Breakthrough Therapy Designation...